Dr. Mohamed Ali Ezz El Arab
Gastroenteroloji
Internal Medicine, Hepatology and Liver Cancer Consultant
Dokki - GizeCairo International Airport
yaklaşık 30 km uzaklıkta
Sphinx International Airport
yaklaşık 20 km uzaklıkta
Grand Egyptian Museum
yaklaşık 20 km uzaklıkta
Dr. Mohamed Ali Ezz El Arab is a Consultant in Internal Medicine and Hepatology, Founder of the Liver Tumor Unit at the National Liver Institute, and Secretary General of the Egyptian Society of Liver Cancer. His professional field focuses on the diagnosis and management of liver diseases, particularly liver tumors and hepatocellular carcinoma.
Liver diseases requiring specialist assessment include viral hepatitis, liver cirrhosis, fatty liver disease, elevated liver enzymes, and the development of liver lesions or tumors. Evaluating these conditions involves reviewing the patient's medical history, laboratory results, and imaging studies to determine the nature and severity of the disease and its effect on liver function.
Liver cancer cases require comprehensive assessment of tumor size, number and location, the presence of cirrhosis or related complications, and the patient's overall health. This evaluation helps determine which treatment options may be appropriate for each individual case.
Patients can submit their medical reports, laboratory results, and imaging through Macrocare to help organize their medical records, coordinate a case review, and arrange a consultation with Dr. Mohamed Ali Ezz El Arab.
Specialties of Dr. Mohamed Ali Ezz El Arab
His medical specialty covers several liver and internal medicine conditions, including:
Liver tumors and hepatocellular carcinoma.
Liver cirrhosis and its complications.
Hepatitis B.
Hepatitis C.
Fatty liver disease.
Elevated liver enzymes.
Chronic liver diseases and inflammation.
Assessment of liver lesions and tumors.
Ascites associated with liver disease.
Cirrhosis complications and portal hypertension.
Liver function assessment and disease monitoring.
Liver Cancer Diagnosis and Hepatocellular Carcinoma Treatment
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. It frequently develops in patients with liver cirrhosis or certain chronic liver diseases.
Early-stage liver cancer may not cause noticeable symptoms. This makes regular monitoring particularly important for patients at increased risk.
Possible symptoms of liver cancer include:
Pain or discomfort in the upper right side of the abdomen.
Unexplained weight loss.
Loss of appetite.
Persistent fatigue.
Abdominal swelling.
Jaundice in some cases.
Worsening liver function in patients with cirrhosis.
Tests used to diagnose liver tumors:
Depending on the patient's condition, investigations may include:
Abdominal ultrasound.
Multiphasic CT scan of the liver.
Liver MRI.
Alpha-fetoprotein (AFP) tumor marker test.
Liver function tests.
Viral hepatitis tests.
Liver tumor biopsy when clinically indicated.
Not every patient requires all these investigations. The appropriate tests depend on the initial assessment and the characteristics of the suspected lesion or tumor.
Liver Cancer Treatment Options
The choice of liver cancer treatment depends on tumor size, number and location, whether the cancer has spread beyond the liver, liver function, the degree of cirrhosis, and the patient's overall health.
Treatment options may include:
Surgical Tumor Resection: May be suitable for selected patients whose liver function allows safe removal of the affected part of the liver.
Radiofrequency Ablation (RFA): Uses heat to destroy certain small liver tumors in selected cases.
Microwave Ablation: Another local treatment option for some liver tumors.
Transarterial Chemoembolization (TACE): Delivers treatment directly to the blood vessels supplying the tumor while reducing its blood supply.
Radioembolization: May be considered in selected cases according to tumor location and characteristics.
Immunotherapy: May be an option for certain patients depending on the stage of the disease and treatment suitability.
Targeted Therapy: May be used in selected cases, particularly in certain stages of advanced liver cancer.
Liver Transplantation: May be considered for carefully selected patients who meet established medical criteria.
Selecting an appropriate treatment requires a comprehensive review of imaging, laboratory results, liver function, and the patient's general condition. Some cases may also require discussion among specialists from different medical disciplines.
Radiofrequency Ablation vs. TACE for Liver Tumors
Radiofrequency Ablation and Transarterial Chemoembolization are local treatment approaches used in selected cases of liver cancer, but they work in different ways.
Radiofrequency Ablation (RFA): A specialized needle is guided into the tumor using imaging techniques. Heat is then applied to destroy the targeted cancer cells. It may be suitable for certain small, localized tumors depending on their size, location, and the patient's condition.
Transarterial Chemoembolization (TACE): A catheter is used to reach the blood vessels supplying the tumor, allowing treatment to be delivered directly to the targeted area.
The choice between these approaches depends on tumor size, number and location, liver function, and the presence of other medical conditions or complications.
Liver Cirrhosis and Its Complications
Liver cirrhosis is a chronic condition in which healthy liver tissue is progressively replaced by scar tissue. It may result from chronic viral hepatitis, fatty liver disease, or other causes of long-term liver injury.
Symptoms vary according to the stage of cirrhosis and may include:
Fatigue and general weakness.
Swelling of the legs.
Fluid accumulation in the abdomen (ascites).
Yellowing of the skin and eyes.
Easy bruising or bleeding.
Changes in awareness or confusion in advanced cases.
Monitoring cirrhosis involves assessing liver function, blood counts, clotting tests, and kidney function, as well as performing imaging and other investigations to detect complications.
Patients with cirrhosis also require regular assessment of their risk of developing liver cancer and an appropriate surveillance plan.
Hepatitis B Diagnosis and Management
Hepatitis B is a viral infection that can become chronic in some patients. Over time, chronic infection may lead to liver inflammation, cirrhosis, and an increased risk of liver cancer.
Assessment may include:
Hepatitis B surface antigen (HBsAg).
Viral load testing (HBV DNA).
Liver enzyme and function tests.
Assessment of liver fibrosis when indicated.
Appropriate imaging and follow-up investigations.
Not every patient with Hepatitis B requires immediate antiviral treatment. The decision depends on viral load, the degree of liver inflammation, the presence of fibrosis or cirrhosis, and other clinical factors.
Hepatitis C Diagnosis and Treatment
Hepatitis C is a recognized cause of chronic liver inflammation and cirrhosis. Advanced fibrosis and cirrhosis may increase the risk of developing liver cancer.
Direct-Acting Antiviral medications (DAAs) are now among the main treatment options for Hepatitis C and achieve high rates of viral clearance in most patients when appropriate treatment regimens are used.
Patient assessment may include:
Hepatitis C antibody testing.
HCV RNA testing to confirm active infection.
Liver function tests.
Assessment of liver fibrosis.
Review of medications and associated medical conditions.
Some patients, particularly those with established cirrhosis, may still require regular liver monitoring after successful viral treatment because the risk of complications may persist.
Fatty Liver Disease
Fatty liver disease occurs when excess fat accumulates in liver cells. It is commonly associated with obesity, diabetes, insulin resistance, and elevated blood lipids.
Fatty liver may not cause noticeable symptoms, but in some patients it can progress to inflammation, fibrosis, and cirrhosis.
Assessment may include:
Liver enzyme tests.
Abdominal ultrasound.
Evaluation of weight and metabolic risk factors.
Assessment of liver fibrosis when indicated.
Management focuses on addressing associated risk factors, including improving nutrition, increasing physical activity, weight reduction when appropriate, and managing diabetes and blood lipid levels.
Elevated Liver Enzymes
Elevated liver enzymes, such as ALT and AST, may indicate inflammation or injury to liver cells. However, these results do not identify the underlying cause on their own.
Possible causes include:
Viral hepatitis.
Fatty liver disease.
Certain medications and supplements.
Autoimmune liver diseases.
Metabolic disorders.
Evaluation involves reviewing the patient's medical history and medications, performing appropriate laboratory tests, and considering liver imaging or additional investigations depending on the results.
Liver Lesions: Benign and Malignant Tumors
Discovering a liver lesion does not necessarily mean that the patient has cancer. Liver lesions may be benign, such as hemangiomas or focal nodular hyperplasia, or they may represent malignant tumors.
Distinguishing between these conditions depends on the lesion's size, appearance, and imaging characteristics, as well as the patient's medical history and the presence of cirrhosis or other risk factors.
Assessment may require a liver MRI or multiphasic CT scan. Additional investigations may be recommended depending on the findings.
Ascites and Complications of Liver Cirrhosis
Ascites refers to the accumulation of fluid inside the abdominal cavity. It can occur in patients with cirrhosis due to portal hypertension and changes in liver function.
Symptoms may include abdominal enlargement, a feeling of fullness, and difficulty breathing in more severe cases.
Assessment may involve clinical examination, blood tests, liver and kidney function tests, and analysis of a sample of abdominal fluid when needed to identify the cause and rule out infection.
Management depends on the severity of the condition and may include dietary sodium restriction, diuretic medications, or fluid drainage when indicated, with monitoring of kidney function and electrolyte levels.
Treatment Approach of Dr. Mohamed Ali Ezz El Arab
The assessment of liver diseases and liver tumors requires a comprehensive approach that considers liver function, the underlying disease, and possible complications.
The evaluation and follow-up process may include:
Reviewing the patient's medical history and previous treatments.
Assessing liver function and viral hepatitis test results.
Reviewing CT scans and MRI studies.
Evaluating the presence and severity of liver fibrosis or cirrhosis.
Identifying the nature, size, and number of liver lesions.
Assessing the stage of liver cancer when present.
Reviewing available treatment options according to the individual case.
Monitoring treatment response and potential complications.
Coordinating with other medical specialties when required.
Experience of Dr. Mohamed Ali Ezz El Arab
Dr. Mohamed Ali Ezz El Arab's provided professional credentials include:
Consultant in Internal Medicine and Hepatology.
Founder of the Liver Tumor Unit at the National Liver Institute.
Secretary General of the Egyptian Society of Liver Cancer.
Why Do Patients Consult Dr. Mohamed Ali Ezz El Arab?
Patients may seek consultation with Dr. Mohamed Ali Ezz El Arab for specialist assessment of liver diseases and liver tumors, particularly when their condition requires a detailed review of laboratory results, imaging studies, and available treatment options.
Key medical topics related to his specialty include:
Liver Cancer – Hepatocellular Carcinoma – Liver Cirrhosis – Hepatitis C – Hepatitis B – Fatty Liver Disease – Elevated Liver Enzymes – Liver Lesions – TACE – Radiofrequency Ablation – Liver Transplant Assessment.
Book an Appointment with Dr. Mohamed Ali Ezz El Arab Through Macrocare
Patients looking for an Internal Medicine and Hepatology Consultant in Egypt or a specialist assessment for liver tumors and hepatocellular carcinoma can contact Macrocare and submit their medical records to help organize the reports, coordinate a case review, and arrange a consultation.
Macrocare can assist with:
Organizing medical records, laboratory results, and imaging.
Coordinating medical case reviews.
Arranging consultations and appointments.
Coordinating related healthcare services when needed.
Helping obtain available treatment cost estimates before proceeding.
Medical Documents Required for Liver and Liver Cancer Case Review
Patients are encouraged to submit the available medical documents relevant to their condition, including:
Liver function tests: ALT, AST, bilirubin, and albumin.
Complete blood count (CBC).
Coagulation tests: PT and INR.
Hepatitis B tests, including HBV DNA when available.
Hepatitis C tests, including HCV RNA when available.
Alpha-fetoprotein (AFP) tumor marker.
Abdominal ultrasound reports.
Multiphasic CT scans of the liver.
Liver MRI scans.
Biopsy or pathology reports, if available.
Previous TACE, ablation, or other treatment reports.
A list of current and previous medications.
What Are the Early Symptoms of Liver Cancer?
Early-stage liver cancer may not cause noticeable symptoms. Regular monitoring is therefore important for people at increased risk, particularly patients with liver cirrhosis and certain chronic liver diseases.
What Imaging Tests Are Needed to Diagnose Liver Cancer?
Investigations may include abdominal ultrasound, multiphasic CT scans, and liver MRI. The appropriate imaging study depends on the characteristics of the lesion and the results of previous investigations.
Does Every Liver Lesion Mean Cancer?
No. Liver lesions can be benign or malignant. Diagnosis depends on their imaging characteristics, size, the patient's medical history, and the presence of cirrhosis or other risk factors.
Can Liver Cancer Be Treated Without Surgery?
Yes. Selected patients may be suitable for non-surgical treatments such as local ablation, TACE, radioembolization, immunotherapy, or targeted therapy. The choice depends on the tumor stage, liver function, and the patient's overall health.
What Is the Difference Between Radiofrequency Ablation and TACE?
Radiofrequency Ablation uses heat to destroy targeted tumor tissue in selected cases. TACE delivers treatment directly to the blood vessels supplying the tumor. The choice depends on tumor size, number and location, as well as liver function.
Does Liver Cirrhosis Increase the Risk of Liver Cancer?
Yes. Liver cirrhosis increases the risk of developing hepatocellular carcinoma. Patients with cirrhosis generally require regular monitoring to detect new liver lesions or changes as early as possible.
Does a Patient Need Liver Monitoring After Recovering from Hepatitis C?
Some patients need continued liver monitoring after successful Hepatitis C treatment, particularly those who had cirrhosis before treatment. Their risk of developing liver cancer may persist even after the virus has been cleared.
What Tests Are Needed for a Patient with Liver Cirrhosis?
Tests may include liver function tests, complete blood count, coagulation tests, and kidney function tests. Imaging may also be required periodically to monitor the liver and screen for liver cancer.
How Can I Book a Consultation with Dr. Mohamed Ali Ezz El Arab?
Patients can contact Macrocare and submit their available laboratory results, imaging studies, and medical reports. The team can help organize the medical file and coordinate a case review and consultation.